Impact of Kenya’s Toxic Chemical Policy on Farmers and Exports

Kenya’s 2025 pesticide ban is more than a policy shift—it’s an overdue confrontation with dangerous agrochemical practices that have long gone unchecked. At the heart of the crackdown is Mancozeb, a fungicide so entrenched in Kenyan agriculture that it’s sprayed like water on tomatoes, potatoes, and maize. Yet this widely used chemical breaks down into ethylene thiourea (ETU)—a probable human carcinogen linked to thyroid harm and reproductive toxicity. Mancozeb has already been banned across the European Union and flagged by multiple global health authorities, but until now, it continued to flow into Kenyan markets with barely a check. Now, alongside Mancozeb, Kenya has also moved to restrict or suspend other hazardous products including chlorpyrifos, acephate, glyphosate, and dimethoate—compounds associated with cancer risks, neurotoxicity, endocrine disruption, and acute poisoning in both humans and animals. In withdrawing 77 toxic products and tightening rules on 202 more, the government is finally rejecting the toxic trade imbalance that treats African countries as chemical dumping grounds. The new policy aligns Kenyan regulation with international best practice: no pesticide can be registered here unless it’s also legal in its country of origin and in developed economies like the EU, USA, Canada, or Australia. It’s a turning point—but not without blowback.

A Report by K24TV

For years, Mancozeb symbolized Kenya’s regulatory inertia: cheap, accessible, and unchallenged despite the mounting science against it. Farmers, often unaware of its dangers, sprayed it without masks or gloves, storing the residues in their homes, their soil, and their food. Chlorpyrifos, a widely used insecticide linked to developmental harm in children, and glyphosate, a herbicide under global scrutiny for carcinogenicity, have followed similar trajectories—popular with farmers but flagged by scientists and health agencies. Now, the state faces a high-stakes transition. Smallholders reliant on these chemicals are being urged toward Integrated Pest Management (IPM) and agroecological alternatives. Yet less than 10% of Kenyan farmers use biopesticides, and most lack training, equipment, or trust in new inputs. The Pest Control Products Board, emboldened by fresh legislation, is finally flexing its oversight powers. But enforcement remains patchy, and counterfeit products exploit the regulatory vacuum. Mancozeb isn’t just a pesticide—it’s a case study in how economic expediency once overrode health and environmental responsibility. That era, Kenya now claims, is ending.

Timing is crucial. The EU is cracking down on residue limits. Kenya’s vegetable exports—once worth KSh 100 billion—have already taken a hit. If the country wants to stay competitive and credible, aligning with global safety standards is not optional. Mancozeb’s fall is both symbolic and strategic: it’s a warning to other harmful substances still in circulation—like profenofos, carbendazim, and triazophos—and a test of whether Kenya can enforce its own reform. This is where political will must hold—beyond press briefings and regulatory memos. Farmers need practical support. Consumers need transparency. And regulators must resist the pressure of well-funded pesticide lobbies looking to reverse course. Kenya has declared its direction. Now the country must walk it—with clarity, speed, and resolve—before the next generation pays the price in poisoned soil, sickened bodies, and lost trade.

References:

Trade World News Kenya Bans Import of 50 Pesticide Brands for Safer Farming

The Standard State cracks down on harmful pesticides, bans 77 products

The Star Civil society demand full disclosure of banned pesticides, calls for safer agricultural reforms

The Star 77 pesticides banned in Kenya as 202 others restricted – CS Kagwe

Kenya News Agency State urged to make to make public list of banned pesticides

Kenyans.co.ke Kenya Bans Use of Pesticides Not Approved in Europe, USA, Canada & Australia

Fake Medicines Threaten Public Health in Kenya

Kenya’s pharmaceutical supply chain is facing a creeping, deadly crisis — one that’s quietly poisoning public trust in healthcare. In 2024 alone, over 30 different drug products were recalled in Kenya, more than doubling the previous year’s figure. This disturbing surge included contaminated pediatric syrups, mislabeled antibiotics, and packaging mix-ups between life-saving cancer drugs and common generics. Some of these were produced by global manufacturers with once-reputable names. The growing scale and severity of these incidents have exposed glaring weaknesses in regulatory enforcement, border control, and supply chain oversight. But beyond the headlines lies a darker story — fake and substandard medicines are no longer rare exceptions; they are becoming routine features in pharmacies, clinics, and even households. As treatment failures rise and drug resistance intensifies, trust in medicine itself is breaking down. Patients increasingly worry: if I walk into a pharmacy, how can I know what I’m buying won’t kill me?

A K24 Report from 2024

The regulator, the Pharmacy and Poisons Board (PPB), is overwhelmed. With just 16 inspectors tasked with overseeing a vast and evolving market — spanning over 10,000 retail outlets, mobile vendors, and now, an unregulated e-pharmacy explosion — enforcement efforts are falling behind. In 2024, the PPB shut down 117 illegal pharmacies, an important but ultimately symbolic move in the face of thousands more operating without licenses or pharmacist supervision. Online drug sales are the new front line. A study found that over 60% of Kenyan e-pharmacies sell restricted drugs like antibiotics and sedatives without prescriptions, bypassing safeguards entirely. These platforms, often disguised as Instagram shops, WhatsApp-based vendors, or websites with fake credentials, target desperate buyers looking for cheap, fast relief. With little digital verification, no pharmacist involvement, and no legal framework to manage or penalize them, the risk of mass harm is escalating. Meanwhile, legitimate pharmacies face the fallout: eroded consumer confidence, a rise in self-medication, and unfair competition from black-market sellers. At the center of it all is a poorly resourced regulator trapped in a battle it cannot win with its current tools.

Fixing this won’t come from a few more closures or stern warnings. What’s needed is a total overhaul of pharmaceutical regulation and public health literacy. The PPB needs financial and legal independence, an expanded workforce, and modern tools — including barcode authentication, blockchain-backed tracking systems, and real-time reporting dashboards for drug recalls and falsifications. E-pharmacies must be brought under legal oversight immediately, with criminal penalties for non-compliant platforms. Consumer protection should no longer be passive; the government must launch aggressive national awareness campaigns to teach people how to identify fake drugs, report suspicious sources, and verify prescriptions. Crucially, Kenya must repair public trust — not just in the pills on pharmacy shelves, but in the very systems meant to safeguard their health. Because when faith in medicine collapses, people don’t stop getting sick — they just stop getting help. This is more than a regulatory failure. It’s a national health emergency — and one that cannot be ignored.

References:

The Eastleigh Voice Inside Kenya’s battle against fake and unsafe medicines

Eurek Alert Curbing harmful medicines: the promise of a unified African health products regulatory system

OECD Dangerous Fakes


Kenya’s Yellow Maize Strategy Offers Relief, But Raises Serious Public Health Concerns

Faced with a deepening maize crisis and the threat of unaffordable unga prices for millions of households, the Kenyan government has authorized the importation of yellow maize under a 50% duty waiver. The policy aims to ease the strain on white maize—Kenya’s staple grain for human consumption—by diverting demand from feed manufacturers. By encouraging millers in the animal feed industry to substitute white maize with yellow maize, the government hopes to reduce competition for white maize, making it more accessible and affordable to food processors and, ultimately, to consumers. However, this economic intervention carries unintended consequences that could undermine its goals. Due to Kenya’s fragmented supply chains and patchy enforcement mechanisms, experts warn that the clear division between maize meant for animals and that meant for humans may not hold. The significantly lower price of the imported yellow maize could tempt unscrupulous traders to redirect it into the human food market—either by blending it with white maize flour or selling it directly in low-income areas where yellow maize is already accepted as food, such as parts of Western Kenya. In places like Homa Bay County, where yellow maize is widely consumed in the form of ugali, this policy shift could unintentionally flood the food supply with grain that may not meet safety standards for human consumption.

A Report by NTV Kenya

The core of the concern lies in the persistent and well-documented threat of aflatoxin contamination, a toxic compound produced by mold that thrives in warm, humid conditions—particularly in improperly stored grains. While Kenya has established aflatoxin limits aligned with East African Community standards—10 parts per billion (ppb) for total aflatoxins and 5 ppb for aflatoxin B1—systemic challenges hinder enforcement. Many small-scale producers, informal traders, and millers lack access to the sophisticated equipment and financial resources needed to test for aflatoxins or implement preventive storage solutions. Furthermore, there have been troubling precedents that cast doubt on the robustness of regulatory oversight. In 2011, a shipment of aflatoxin-contaminated maize from the U.S. was allegedly released into the market despite being flagged by authorities, with reports suggesting that the Kenya Bureau of Standards (KEBS) was blocked from conducting proper inspections. More recently, in January 2025, a 2,000-tonne shipment of rice from Pakistan was found to exceed aflatoxin limits, indicating that lapses in import control remain a pressing issue. These incidents demonstrate that having regulations on paper is not enough—especially when imports labeled for animal feed, which undergo less rigorous scrutiny, may be co-opted into the human food chain in the absence of strict monitoring, reliable segregation mechanisms, and transparent accountability.

The potential health implications of increased aflatoxin exposure are grave and far-reaching, especially for vulnerable populations who rely heavily on maize as their primary food source. Acute exposure can lead to severe liver damage, jaundice, and even death, while long-term, low-level exposure is linked to liver cancer, immune system suppression, nutrient malabsorption, and developmental issues in children. Infants and young children face elevated risks due to their small body mass and the fact that complementary weaning foods are often maize-based, yet specific aflatoxin regulations for these products are either absent or poorly enforced. For populations with pre-existing liver conditions, Hepatitis B infections, or compromised immunity—such as people living with HIV—the health risks are significantly amplified. Malnourished individuals and rural subsistence farmers, who often rely on their own poorly stored harvests, are also at heightened risk. In the face of this looming danger, health advocates and food safety experts are calling on the Kenyan government to urgently invest in comprehensive and well-coordinated countermeasures. These include rigorous aflatoxin testing of all maize imports, stricter enforcement to prevent feed-grade yellow maize from entering the human food stream, large-scale public education campaigns targeting high-risk regions, and long-term investments in improved post-harvest storage infrastructure. Without such measures, the policy designed to stabilize food prices could inadvertently trigger a public health emergency—one that disproportionately affects the country’s poorest and most vulnerable.

References:

Nation Kagwe bows to pressure, opens imports as unga prices hit 13-month high

Jijuze Maize Prices Surge: Impact on Kenya’s Livestock and Food Security

Milling Middle East & Africa Kenya to halt maize, sugar imports in 2025 after achieving self-sufficiency

The Star Why state will allow importation 5.5 million bags of yellow maize – Kagwe

Randox Food Diagnostics Kenyans at risk of aflatoxin contamination as KEBS flags 2,000-tonne rice shipment

Business Daily Turn Kenya farms yellow with maize for food security







Children’s Toys in Kenya: A Cancer Risk Uncovered

A shocking new report has just been released, sending alarm bells ringing across Kenya. Environmental activists are urgently warning that many children’s toys currently on sale are riddled with cancer-causing chemicals, most notably phthalates, according to the groundbreaking ‘Dangerous Fun: A Price of Play’ study. This investigation, conducted by CEJAD, ARNIKA, and IPEN, meticulously analyzed a range of popular PVC plastic toys – from dolls and inflatable playthings to teething rings and even a Spiderman costume – and the results are deeply disturbing. Every single toy tested contained phthalates, insidious chemicals used to soften plastic, alongside a cocktail of other hazardous substances including UV stabilizers, chlorinated paraffin, and toxic heavy metals. These aren’t just trace amounts; the inflatable Spiderman suit was found to be saturated with these dangerous additives at levels far exceeding safe limits. This revelation demands immediate attention from every parent and caregiver in Kenya: the very items we entrust to our children for joy and development may be silently poisoning them.

A Report by Curiosity Chronicles

The medical implications of these findings are profound and deeply concerning. Phthalates are not inert substances; they are known endocrine disruptors, meaning they interfere with the delicate hormonal systems that govern growth, development, reproduction, and even the immune system. Exposure to these chemicals, particularly during the critical developmental stages of childhood, has been linked in numerous scientific studies to a terrifying array of health problems. These include an increased risk of certain cancers, harm to children’s reproductive development, impaired immune system function, and potential damage to the liver and kidneys. Young children are especially vulnerable as they often mouth toys, leading to direct ingestion of these toxins. Furthermore, exposure can occur through skin contact and inhalation of chemical vapors released from the plastic. The fact that all tested toys contained phthalates underscores a widespread and systemic problem, demanding urgent action to protect the health and future of Kenyan children who are unknowingly being exposed to these hazardous substances through their everyday playthings.

This is not a matter to be taken lightly. The time for complacency is over. Parents must be empowered with knowledge to make informed choices, and this report serves as a stark wake-up call. We urgently need comprehensive public awareness campaigns to educate families about the dangers lurking in these seemingly harmless toys and how to identify safer alternatives. Simultaneously, policymakers and the Kenya Bureau of Standards must act decisively to strengthen regulations on the chemical content of children’s products, ensuring stricter limits and thorough enforcement to prevent these toxic toys from reaching our markets. Manufacturers and retailers must also be held accountable for the safety of their products, prioritizing the health of children over profit. The ‘Dangerous Fun’ report has laid bare a serious threat to the well-being of Kenya’s youngest citizens. We must collectively demand and enact immediate changes to ensure that play remains a source of joy and development, not a pathway to potential life-threatening illnesses. The health of our children is non-negotiable.

References:

Jijuze Children’s Health at Risk: The Impact of Endocrine-Disrupting Chemicals in Personal Care Products

The Star Your child’s toys may contain cancer-causing chemicals, activists warn

Kenya News Agency Study reveals harmful chemicals in plastic toys

Vaccines Work Plastics are invading our bodies, not just our oceans

IPEN Highly Toxic Chemicals from Plastic Waste Contaminate Kenya’s Food Chain and Products